Clerkenwell Health have signed their first multi-million pound contract to design and run multi-phase trials with Psyence Group. Psyence Group is a Canadian-listed life science biotechnology company Clerkenwell is a specialist psychedelic Contract Research Organisation (CRO) based in the United Kingdom The first studies will examine the effectiveness of psilocybin-assisted therapy to help patients…


Previous articleReal World Research in Psychedelic Science
Next articleMYND Life Sciences Provides Corporate Update